Palo Alto Investors LP Q3 2025 Filing
Filed November 14, 2025
Portfolio Value
$540.4B
Holdings
44
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (44 positions)
| Stock | Value |
|---|---|
IM8NINSMED INC | $70.8M |
PTCTPTC THERAPEUTICS INC | $52.9M |
ACADACADIA PHARMACEUTICALS INC | $52.6M |
AM6AMICUS THERAPEUTICS INC | $42.3M |
BMRNBIOMARIN PHARMACEUTICAL INC | $40.8M |
BIIBBIOGEN INC | $26.0M |
UTHUNITED THERAPEUTICS CORP | $24.4M |
ANABANAPTYSBIO INC | $20.6M |
IOVAIOVANCE BIOTHERAPEUTICS INC | $16.5M |
NVCRNOVOCURE LTD | $16.2M |
DYNDYNE THERAPEUTICS INC | $16.0M |
IRONDISC MEDICINE INC | $14.8M |
ALNYALNYLAM PHARMACEUTICALS INC | $14.7M |
GOSSGOSSAMER BIO INC | $14.4M |
PRTAPROTHENA CORP PLC | $12.9M |
RAREULTRAGENYX PHARMACEUTICAL IN | $11.1M |
AGIOAGIOS PHARMACEUTICALS INC | $10.7M |
SNDXSYNDAX PHARMACEUTICALS INC | $10.1M |
EHTHEHEALTH INC | $6.7M |
DNLIDENALI THERAPEUTICS INC | $5.9M |
AFWALIGN TECHNOLOGY INC | $5.7M |
ALKSALKERMES PLC | $5.5M |
RNAAVIDITY BIOSCIENCES INC | $4.8M |
MIRMMIRUM PHARMACEUTICALS INC | $4.7M |
CDNACAREDX INC | $4.6M |
TSHATAYSHA GENE THERAPIES INC | $4.1M |
NUVBNUVATION BIO INC | $3.8M |
ACRSACLARIS THERAPEUTICS INC | $3.0M |
CRSPCRISPR THERAPEUTICS AG | $2.7M |
TVTXTRAVERE THERAPEUTICS INC | $2.6M |
EWEDWARDS LIFESCIENCES CORP | $2.6M |
NBIXNEUROCRINE BIOSCIENCES INC | $2.5M |
STOKSTOKE THERAPEUTICS INC | $2.5M |
PYXSPYXIS ONCOLOGY INC | $2.3M |
BNTXBIONTECH SE-ADR | $1.9M |
BCYCBICYCLE THERAPEUTICS PLC-ADR | $1.7M |
ALDXALDEYRA THERAPEUTICS INC | $1.2M |
HUMHUMANA INC | $1.0M |
ORKAORUKA THERAPEUTICS INC | $791K |
ABEOABEONA THERAPEUTICS INC | $575K |
URGNUROGEN PHARMA LTD | $489K |
PRQRPROQR THERAPEUTICS NV | $402K |
AKTXAKARI THERAPEUTICS PLC-ADR | $147K |
GBIOGBXGENERATION BIO CO | $92K |